BRAF a serine/threonine kinase, known to activate the MAPK pathway has been found mutated in several tumours, namely melanoma, colorectal carcinoma and thyroid carcinoma [3,4,26]. The gene discussed is MARK2; the disease is colorectal carcinoma.